Literature DB >> 25524376

[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].

Perry M Elliott, Aris Anastasakis1, Michael A Borger, Martin Borggrefe, Franco Cecchi, Phillippe Charron, Albert Alain Hagege, Antoine Lafont, Giuseppe Limongelli, Heiko Mahrholdt, Wiliam J McKenna, Jens Mogensen, Petros Nihoyannopoulos, Stefano Nistri, Petronella G Pieper, Burkert Pieske, Claudio Rapezzi, Frans H Rutten, Christoph Tillmanns, Hugh Watkins.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25524376     DOI： 10.5603/KP.2014.0212

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  10 in total

1.  Extended Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in Children and Adolescents.

Authors:  Haitao Xu; Jun Yan; Qiang Wang; Dianyuan Li; Hongwei Guo; Shoujun Li; Ju Wang; Song Lou; Qingdong Zeng
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

2.  Hypertrophic obstructive cardiomyopathy-the Leipzig experience.

Authors:  Jawad Khalil; Michael Kuehl; Pirose Davierwala; Friedrich Wilhelm Mohr; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 3.  Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

Authors:  F Sedaghat-Hamedani; H A Katus; B Meder
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

4.  Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy.

Authors:  Seyed Amir Mirmojarabian; Eveliina Lammentausta; Esa Liukkonen; Lauri Ahvenjärvi; Juhani Junttila; Miika T Nieminen; Timo Liimatainen
Journal:  Int J Biomed Imaging       Date:  2022-06-23

5.  Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients.

Authors:  Monika Kobediona; Jozef Bartunek; Leen Delrue; Frederik Van Durme; Chirik Wah Lau; Ana Moya; Sofie Verstreken; Ward Heggermont; Riet Dierckx; Marc Goethals; Marc Vanderheyden
Journal:  Transplant Direct       Date:  2022-05-26

6.  Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.

Authors:  Da-Jun Hu; Jing Xu; Wei Du; Jian-Xin Zhang; Min Zhong; Ya-Nan Zhou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-26       Impact factor: 2.357

7.  Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.

Authors:  Carol Ko; Patricia Arscott; Maryann Concannon; Sara Saberi; Sharlene M Day; Beverly M Yashar; Adam S Helms
Journal:  Genet Med       Date:  2017-06-22       Impact factor: 8.822

8.  Spectrum of cardiovascular diseases at a referral tertiary care hospital in Somalia, Mogadishu: an echocardiographic study.

Authors:  Gökhan Alıcı; Ömer Genç
Journal:  BMC Cardiovasc Disord       Date:  2021-12-16       Impact factor: 2.298

9.  Palpitation was associated with clinical outcomes in patients with hypertrophic cardiomyopathy.

Authors:  Tingting Hu; Tao Wang; Xiwen Zhang
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

10.  Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.

Authors:  Arka Das; Christopher Kelly; Irvin Teh; Christopher Nguyen; Louise A E Brown; Amrit Chowdhary; Nicholas Jex; Sharmaine Thirunavukarasu; Noor Sharrack; Miroslawa Gorecka; Peter P Swoboda; John P Greenwood; Peter Kellman; James C Moon; Rhodri H Davies; Luis R Lopes; George Joy; Sven Plein; Jürgen E Schneider; Erica Dall'Armellina
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-02-22       Impact factor: 6.875
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.